- Filed
- Sep 4, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2026 · Jul 31, 2025 | 263.2M sh |
| Shares Diluted | Q2 2026 · Jul 31, 2025 | 264.44M sh |
| Shares Diluted | Q2 2026 · Jul 31, 2024 | 271.93M sh |
| Shares Diluted | Q2 2026 · Jul 31, 2024 | 279.7M sh |
| Stock Repurchased | Q2 2026 · Jul 31, 2025 | $140.85M |
| Stock Repurchased | Q2 2026 · Jul 31, 2024 | $273.87M |
| Capex | Q2 2026 · Jul 31, 2025 | $654K |
| Capex | Q2 2026 · Jul 31, 2024 | $4.03M |
| Operating Cash Flow | Q2 2026 · Jul 31, 2025 | $118.57M |
| Operating Cash Flow | Q2 2026 · Jul 31, 2024 | $63.03M |
| Cash And Equivalents | Q2 2026 · Jul 31, 2025 | $125.37M |
| Cash And Equivalents | Q2 2026 · Jan 31, 2025 | $145.27M |
| Stockholders Equity | Q2 2026 · Jul 31, 2025 | $543.44M |
| Stockholders Equity | Q2 2026 · Apr 30, 2025 | $639.77M |
| Stockholders Equity | Q2 2026 · Jan 31, 2025 | $612.06M |
| Stockholders Equity | Q2 2026 · Jul 31, 2024 | $468.97M |
| Stockholders Equity | Q2 2026 · Apr 30, 2024 | $610.93M |
| Stockholders Equity | Q2 2026 · Jan 31, 2024 | $679.7M |
| Current Liabilities | Q2 2026 · Jul 31, 2025 | $493.92M |
| Current Liabilities | Q2 2026 · Jan 31, 2025 | $517.58M |
| Total Liabilities | Q2 2026 · Jul 31, 2025 | $542.68M |
| Total Liabilities | Q2 2026 · Jan 31, 2025 | $572.14M |
| Current Assets | Q2 2026 · Jul 31, 2025 | $767.18M |
| Current Assets | Q2 2026 · Jan 31, 2025 | $854.1M |
| Total Assets | Q2 2026 · Jul 31, 2025 | $1.09B |
| Total Assets | Q2 2026 · Jan 31, 2025 | $1.18B |
| Eps Diluted | Q2 2026 · Jul 31, 2025 | $0.05 |
| Eps Diluted | Q2 2026 · Jul 31, 2025 | $0.04 |
| Eps Diluted | Q2 2026 · Jul 31, 2024 | $0.01 |
| Eps Diluted | Q2 2026 · Jul 31, 2024 | $0.04 |
| Eps Basic | Q2 2026 · Jul 31, 2025 | $0.05 |
| Eps Basic | Q2 2026 · Jul 31, 2025 | $0.04 |
| Eps Basic | Q2 2026 · Jul 31, 2024 | $0.01 |
| Eps Basic | Q2 2026 · Jul 31, 2024 | $0.05 |
| Sga Expense | Q2 2026 · Jul 31, 2025 | $35.57M |
| Sga Expense | Q2 2026 · Jul 31, 2025 | $70M |
| Sga Expense restated | Q2 2026 · Jul 31, 2024 | $38.78M |
| Sga Expense restated | Q2 2026 · Jul 31, 2024 | $67.88M |
| Rd Expense | Q2 2026 · Jul 31, 2025 | $23.16M |
| Rd Expense | Q2 2026 · Jul 31, 2025 | $45.97M |
| Rd Expense restated | Q2 2026 · Jul 31, 2024 | $23.23M |
| Rd Expense restated | Q2 2026 · Jul 31, 2024 | $45.77M |
| Net Income | Q2 2026 · Jul 31, 2025 | $12.62M |
| Net Income | Q2 2026 · Jul 31, 2025 | $11.05M |
| Net Income | Q2 2026 · Jul 31, 2024 | $1.84M |
| Net Income | Q2 2026 · Jul 31, 2024 | $12.48M |
| Operating Income | Q2 2026 · Jul 31, 2025 | $16.27M |
| Operating Income | Q2 2026 · Jul 31, 2025 | $14.52M |
| Operating Income | Q2 2026 · Jul 31, 2024 | −$87K |
| Operating Income | Q2 2026 · Jul 31, 2024 | $5.62M |
| Gross Profit | Q2 2026 · Jul 31, 2025 | $144.6M |
| Gross Profit | Q2 2026 · Jul 31, 2025 | $287.47M |
| Gross Profit restated | Q2 2026 · Jul 31, 2024 | $143.24M |
| Gross Profit restated | Q2 2026 · Jul 31, 2024 | $288.07M |
| Cost Of Revenue | Q2 2026 · Jul 31, 2025 | $67.44M |
| Cost Of Revenue | Q2 2026 · Jul 31, 2025 | $130.07M |
| Cost Of Revenue restated | Q2 2026 · Jul 31, 2024 | $53.97M |
| Cost Of Revenue restated | Q2 2026 · Jul 31, 2024 | $105.09M |
| Revenue | Q2 2026 · Jul 31, 2025 | $212.04M |
| Revenue | Q2 2026 · Jul 31, 2025 | $417.54M |
| Revenue | Q2 2026 · Jul 31, 2024 | $197.21M |
| Revenue | Q2 2026 · Jul 31, 2024 | $393.17M |